Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 5Pain, Postoperative 4Pituitary Neoplasms 3Neoplasms 2Liver Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Supratentorial Neoplasms 1Sleep Initiation and Maintenance Disorders 1Rectal Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pain 1Neuroinflammatory Diseases 1Neurofibromatoses 1Neurocognitive Disorders 1Lung Neoplasms 1Kidney Neoplasms 1Hypoxia 1Hydrocephalus 1Headache 1Epilepsy 1Colonic Neoplasms 1Chronic Pain 1Agnosia 1Abdominal Neoplasms 1Abdominal Cancer Surgery 1Abdominal Cancer Surgeries 1

Interventions

Sodium Chloride 1Saline Solution 1Propofol 1Dexmedetomidine 1Alfentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hypoxia × Dexmedetomidine × Clear all
NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Aristotle University Of Thessaloniki

Phase 4 Completed
56 enrolled
CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡